Colorectal Carcinoma: Pathologic Aspects and Treatment
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: closed (1 August 2023)
Special Issue Editor
Interests: colorectal cancer; cancer metabolism; autophagy; drug repositioning, natural products; cancer treatment;
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Modern lifestyles have undoubtedly influenced the increase in the incidence of colorectal cancer (CRC) around the world. We are aware that this type of cancer not only has a genetic component, but is also a consequence of two fundamental factors, which are sedentary lifestyle and the abuse of processed foods high in salt and added sugars. Thus, the scientific community—conducting both basic and clinical research—is dedicating efforts to deepen our knowledge on the pathogenesis of this disease and to propose new treatments.
Genetic and environmental factors contribute to CRC development by promoting the acquisition of cancer hallmarks due to the accumulation of genetic and epigenetic mutations that activate oncogenes and inactivate tumor suppressor genes (Hanahan and Weinberg, 2011), which progressively affect various signaling pathways within colon epithelial cells. Different mechanisms of molecular progression by which CRC can develop have been defined. Ongoing research into the physiological aspects that lead to the development of colon cancer is relevant for finding appropriate, efficient and successful treatments.
The incidence of colon cancer occupies a worrying place in health statistics worldwide. Therefore, it is of paramount importance to publicize current advances in our knowledge of the disease, its spread and areas of opportunity to attack it. In this Special Issue, we encourage researchers to submit reviews or original articles on current advances in colon cancer treatment, future perspectives in personalized medicine and drug repositioning.
Dr. Nadia Judith Jacobo-Herrera
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- carcinoma
- pathologic aspects
- opportunities for new treatments in cancer
- cell metabolism
